ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.520
-0.010 (-0.28%)
At close: Jan 2, 2026, 4:00 PM EST
3.520
0.00 (0.00%)
After-hours: Jan 2, 2026, 5:40 PM EST
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $436.05 million as of January 2, 2026. Its market cap has increased by 138.61% in one year.
Market Cap
436.05M
Enterprise Value
659.98M
1-Year Change
138.61%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $436.05M, a decrease of -78.65%. That is a compound annual growth rate of -23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |